Keyphrases
Indonesian
73%
Pediatric
71%
Pediatric COVID-19
66%
Data Registry
66%
Preterm Infants
66%
Phototherapy
66%
Indonesia
59%
Total Bilirubin
58%
Test Agreement
33%
Incomplete Information
33%
School Reopening
33%
Postnatal Growth Failure
33%
Ophthalmic Solutions
33%
Neonatal Indirect Hyperbilirubinemia
33%
Ursodeoxycholic Acid
33%
Eye Ointment
33%
Meta-analysis of Randomized Controlled Trials
33%
Parent Perspectives
33%
Protein Use
33%
L-type Fatty Acid-binding Protein
33%
Bilistick
33%
Case Fatality Rate
33%
Chloramphenicol
33%
Bacterial Colony
33%
Systematic Meta-analysis
33%
Gut Microbiota
33%
COVID-19 Pandemic
33%
Povidone-iodine (PVP-I)
33%
Acute Diarrhea
33%
COVID-19 Cases
33%
Conjunctiva
33%
Transcutaneous Bilirubin
33%
National Survey
33%
COVID-19 Data
25%
Weight-for-age z Score
23%
Comorbidity
21%
Transcutaneous Bilirubinometer
20%
Ministry of Health
16%
Methods Section
16%
COVID-19 in children
16%
Meta-analysis
16%
Dysbiosis
16%
Bifidobacterium
16%
Neonatal Jaundice
16%
COVID-19
16%
Ex-preterms
15%
Bacterial Patterns
13%
COVID-19 Mortality
13%
Bilirubin Measurement
12%
Clostridium
12%
Medicine and Dentistry
COVID-19
100%
Pediatrics
71%
Neonatal Infant
41%
Randomized Controlled Trial
40%
Ursodeoxycholic Acid
33%
Eye Ointment
33%
Eye Drops
33%
Chloramphenicol
33%
Meta-Analysis
33%
Phototherapy
33%
Bacterium Colony
33%
Povidone Iodine
33%
Systematic Review
33%
Hyperbilirubinemia
33%
Probiotic Agent
33%
Gut Microbiota
33%
Acute Diarrhea
33%
Bilirubin
25%
Developmental Milestone
16%
Neonatal Jaundice
16%
Dysbiosis
16%
Placebo
16%
Bifidobacterium
16%
Gram-Positive Bacteria
13%
Clostridium
12%
Case Fatality Rate
11%
Disease
8%
Enterobacter
8%
Random Effects Model
8%
Diarrhea
8%
Neonate
8%
Subgroup Analysis
8%
Group Therapy
8%
Lactobacillus
8%
Adjuvant Therapy
8%
Newborn Ophthalmia
6%
Cost-Effectiveness Analysis
6%
Colony Forming Unit
6%
Adverse Event
6%
Childbirth
6%
Gram-Negative Bacteria
6%
Conjunctivitis
6%
Bacterial Growth
6%
Pharmacology, Toxicology and Pharmaceutical Science
Bilirubin
66%
Prematurity
36%
Growth Disorder
33%
Case Fatality Rate
33%
Ursodeoxycholic Acid
33%
Intestine Flora
33%
Fatty Acid Binding Protein
33%
Hyperbilirubinemia
33%
Probiotic Agent
33%
Premature Labor
33%
Acute Diarrhea
33%
Randomized Controlled Trial
33%
Newborn Jaundice
22%
Prospective Cohort Study
19%
Comorbidity
16%
Bifidobacterium
16%
Visual Impairment
16%
Dysbiosis
16%
Hearing Impairment
16%
Placebo
16%
Survival Rate
16%
Clostridium
12%
Random Effects Model
11%
Prevalence
10%
Retrospective Study
8%
Respiratory Failure
8%
Fatality
8%
Diarrhea
8%
Lactobacillus
8%
Enterobacter
8%
